Availability and Utilization of Opioids for Pain Management: Global Issues

REFERENCES

1. ↵
   1. International Association for the Study of Pain

   (9, 2004) Pain: Clinical updates, 12(5):1–4, http://iasp.files.cms-plus.com/Content/ContentFolders/Publications2/PainClinicalUpdates/Archives/PCU04-5_1390264543538_30.pdf. Accessed March 19, 2014.
2. ↵
   1. International Association for the Study of Pain

   (2011) Classification of Chronic Pain (International Association for the Study of Pain; Washington, DC).
3. ↵
   1. Melzack R

   (2, 1990) The tragedy of needless pain. Sci Am 262(2):27–33, pmid:2296714.

   OpenUrlPubMedWeb of Science
4. ↵
   1. Brennan F,
   2. Carr DB,
   3. Cousins M

   (7, 2007) Pain management: a fundamental human right. Anesth Analg 105(1):205–221, pmid:17578977.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Human Rights Watch

   (2009) Access to pain treatment as a human right. Executive summary (Human Rights Watch, New York, NY) http://www.hrw.org/en/reports/2009/03/02/please-do-not-make-us-suffer-any-more-0. Accessed March 19, 2014.
6. ↵
   1. Merskey H,
   2. Bogduk N

   (1994) Classification of Chronic Pain. 2^nd ed (International Association for the Study of Pain Press; Seattle, WA) eds.
7. ↵
   1. Portenoy RK,
   2. Lesage P

   (5 15, 1999) Management of cancer pain. Lancet 353(9165):1695–1700, pmid:10335806.

   OpenUrlCrossRefPubMedWeb of Science
8. ↵
   1. United Nations Office on Drugs and Crime

   (2007) World Drug Report (United Nations, Vienna, Austria), (New York, NY) http://www.unodc.org/pdf/research/wdr07/WDR_2007.pdf. Accessed March 19, 2014.
9. ↵
   1. Milani B,
   2. Sholten W

   (2011) The World Medicines Situation: Access to Controlled Medicines. 3^rd ed (World Health Organization; Geneva, Switzerland).
10. ↵
    1. World Health Organization

    (6, 2010) Medicine: access to controlled medicines (narcotic and psychotropic substances) (World Health Organization), http://www.who.int/mediacentre/factsheets/fs336/en/. Accessed March 19, 2014.
11. ↵
    1. International Narcotics Control Board

    (2011) Report of the International Narcotics Control Board on the Availability of Internationally Controlled Drugs: Ensuring Adequate Access for Medical and Scientific Purpose (International Narcotics Control Board; New York, NY).
12. ↵
    1. De Lima L

    (2, 2004) Opioid availability in Latin America as a global problem: a new strategy with regional and national effects. J Palliat Med 7(1):97–103, pmid:15000793.

    OpenUrlCrossRefPubMed
13. ↵
    1. Silbermann M

    (4, 2011) Current trends in opioid consumption globally and in Middle Eastern countries. J Pediatr Hematol Oncol 33(Suppl 1):S1–S5, pmid:21448027.

    OpenUrlCrossRefPubMed
14. ↵
    1. Pain & Policy Studies Group, World Health Organization Collaborating Center for Policy and Communications in Cancer Care, University of Wisconsin Comprehensive Cancer Center

    (2002) Availability of Opioid Analgesics in Asia: Consumption Trends, Resources, Recommendations (University of Wisconsin Pain & Policy Studies Group, Madison, WI) http://s3.amazonaws.com/zanran_storage/www.painpolicy.wisc.edu/ContentPages/890535482.pdf. Accessed March 19, 2014.
15. ↵
    1. International Narcotics Control Board

    (2008) Report of the International Narcotics Control Board for 2007 (United Nations; New York, NY).
16. ↵
    1. United Nations Office on Drugs and Crimes

    (2011) World Drug Report. The Opium/Heroin Market (United Nations, New York, NY) http://www.unodc.org/documents/data-and-analysis/WDR2011/The_opium-heroin_market.pdf. Accessed March 19, 2014.
17. ↵
    1. Seya MJ,
    2. Gelders SF,
    3. Achara OU,
    4. Milani B,
    5. Scholten WK

    (2011) A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels. J Pain Palliat Care Pharmacother 25(1):6–18, pmid:21426212.

    OpenUrlCrossRefPubMed
18. ↵
    1. United Nations Office on Drugs and Crime

    (1972) Single Convention on Narcotic Drugs, 1961. As Amended by the 1971 Protocol Amending the Single Convention on Narcotic Drugs, 1961 (United Nations, New York, NY) https://www.unodc.org/unodc/en/treaties/single-convention.html. Accessed March 19, 2014.
19. ↵
    1. United Nations Office on Drugs and Crime

    (2012) Afghanistan: Opium Survey 2012 (United Nations; New York, NY).
20. ↵
    1. Taylor AL,
    2. Gostin LO,
    3. Pagonis KA

    (1 2, 2008) Ensuring effective pain treatment: a national and global perspective. JAMA 299(1):89–91, pmid:18167410.

    OpenUrlCrossRefPubMed
21. ↵
    1. Cherny NI,
    2. Catane R,
    3. Kosmidis PA

    (6, 2006) Problems of opioid availability and accessibility across Europe: ESMO tackles the regulatory causes of intolerable and needless suffering. Ann Oncol 17(6):885–887, pmid:16627549, Epub 2006 Apr 20.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    1. Office for National Statistics

    (2012) Cancer Incidence and Mortality in the UK, 2007-2009 (Office for National Statistics; London, England).
23. ↵
    1. British Pain Society

    (2010) Cancer Pain Management (British Pain Society; London, England).
24. 1. Hill CS Jr.

    (4, 1993) The barriers to adequate pain management with opioid analgesics. Semin Oncol 20((2 Suppl 1)):1–5, pmid:8097339.

    OpenUrlPubMedWeb of Science
25. ↵
    1. British Pain Society

    (2005) The Use of Drugs Beyond Licence in Palliative Care and Pain Management (The Association for Palliative Medicine and the British Pain Society; London, England).
26. ↵
    1. Fotedar KK

    (2013) WHO ladder—relevance in today's world. Int J of Perioperative Ultrasound and Appl Technol. May-August 2(2):49–53.

    OpenUrl
27. ↵
    1. World Health Organization

    (1996) Cancer Pain Relief. 2^nd ed (World Health Organization; Geneva, Switzerland).
28. ↵
    1. British Pain Society

    (2010) Opioids for Persistent Pain: Good Practice (British Pain Society; London, England).
29. ↵
    1. British Pain Society

    (2007) Pain and Problem Drug Use: Information for Patients (British Pain Society, London, England) http://www.britishpainsociety.org/book_misuse_patients.pdf. Accessed March 19, 2014.
30. ↵
    1. Green CR,
    2. Anderson KO,
    3. Baker TA,
    4. et al.

    (9, 2003) The unequal burden of pain: confronting racial and ethnic disparities in pain. Pain Med 4(3):277–294, pmid:12974827, Erratum in: Pain Med. 2005 Jan-Feb;6(1):99.

    OpenUrlCrossRefPubMed
31. ↵
    1. Bair MJ,
    2. Matthias MS,
    3. Nyland KA,
    4. et al.

    (10, 2009) Barriers and facilitators to chronic pain self-management: a qualitative study of primary care patients with comorbid musculoskeletal pain and depression. Pain Med 10(7):1280–1290, pmid:19818038.

    OpenUrlCrossRefPubMed
32. ↵
    1. US Census Bureau

    (2008) Number of older americans. AgingStats.gov, http://www.agingstats.gov/Agingstatsdotnet/Main_Site/Data/2008_Documents/Population.aspx. Accessed March 19, 2014.
33. ↵
    1. Gordon DB,
    2. Dahl JL,
    3. Miaskowski C,
    4. et al.

    (7 25, 2005) American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force. Arch Intern Med 165(14):1574–1580, pmid:16043674.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    1. Meier DE

    (1, 2006) Palliative care in hospitals. J Hosp Med 1(1):21–28, pmid:17219467.

    OpenUrlCrossRefPubMed
35. ↵
    1. Jemal A,
    2. Siegel R,
    3. Ward E,
    4. Hao Y,
    5. Xu J,
    6. Thun MJ

    (Jul-Aug 2009) Cancer statistics, 2009. CA Cancer J Clin 59(4):225–249, pmid:19474385, Epub 2009 May 27.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    1. Deandrea S,
    2. Montanari M,
    3. Moja L,
    4. Apolone G

    (12, 2008) Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 19(12):1985–1991, pmid:18632721, Epub 2008 Jul 15.

    OpenUrlCrossRefPubMedWeb of Science
37. ↵
    1. MacDonald N,
    2. Ayoub J,
    3. Farley J,
    4. Foucault C,
    5. Lesage P,
    6. Mayo N. A

    (1, 2002) Quebec survey of issues in cancer pain management. J Pain Symptom Manage 23(1):39–47, pmid:11779667.

    OpenUrlCrossRefPubMedWeb of Science
38. ↵
    1. Ministry of Health Malaysia

    (2010) Management of Cancer Pain (Ministry of Health Malaysia, Putrajaya, Malaysia) http://www.acadmed.org.my/index.cfm?&menuid=67. Accessed March 19, 2014.
39. ↵
    1. Devi BC,
    2. Tang TS,
    3. Corbex M

    (12, 2008) Setting up home-based palliative care in countries with limited resources: a model from Sarawak, Malaysia. Ann Oncol 19(12):2061–2066, pmid:18641007, Epub 2008 Jul 17.

    OpenUrlCrossRefPubMedWeb of Science
40. ↵
    1. Murthy NS,
    2. Chaudhry K,
    3. Rath GK

    (Oct-Dec 2008) Burden of cancer and projections for 2016, Indian scenario: gaps in the availability of radiotherapy treatment facilities. Asian Pac J Cancer Prev 9(4):671–677, pmid:19256757.

    OpenUrlPubMedWeb of Science
41. ↵
    1. Murthy NS,
    2. Juneja A,
    3. Sehgal A,
    4. Prabhakar AK,
    5. Luthra UK

    (6, 1990) Cancer projection by the turn of century-Indian science. Indian J Cancer 27(2):74–82, pmid:2228015.

    OpenUrlPubMed
42. ↵
    1. Takiar R,
    2. Nadayil D,
    3. Nandakumar A

    (2010) Projections of number of cancer cases in India (2010-2020) by cancer groups. Asian Pac J Cancer Prev 11(4):1045–1049, pmid:21133622.

    OpenUrlPubMed
43. ↵
    1. Redmond K

    (11, 1997) Organizational barriers in opioid use. Support Care Cancer 5(6):451–456, pmid:9406358.

    OpenUrlPubMed
44. ↵
    1. Rajagopal MR,
    2. Joranson DE,
    3. Gilson AM

    (7 14, 2001) Medical use, misuse, and diversion of opioids in India. Lancet 358(9276):139–143, pmid:11463435.

    OpenUrlCrossRefPubMedWeb of Science
45. ↵
    1. Grant M,
    2. Elk R,
    3. Ferrell B,
    4. Morrison RS,
    5. von Gunten CF

    (Sep-Oct 2009) Current status of palliative care—clinical implementation, education, and research. CA Cancer J Clin 59(5):327–335, pmid:19729681.

    OpenUrlCrossRefPubMed
46. ↵
    1. Varghese C

    (2002) Cancer Prevention and Control in India (National Cancer Control Programme, New Delhi, India) http://www.indg.in/india/sitemap-1/health/national_health_programmes/Cancer%20Prevention%20and%20Control%20in%20India.pdf. Accessed March 19, 2014.
47. ↵
    1. Pain & Policy Studies Group

    (2002) Availability of Opioid Analgesics in Latin America and the World (Guadalajara, Mexico) Prepared for: 1^st Congress of the Latin American Association of Palliative Care, 7^th Latin American course on medicine and palliative care; March 20-22.
48. ↵
    1. De Lima L,
    2. Bruera E,
    3. Joranson DE,
    4. et al.

    (1997) Opioid availability in Latin America: the Santo Domingo report. Progress since the Declaration of Florianopolis. J Pain Symptom Manage 13(4):213–219, pmid:9136232.

    OpenUrlCrossRefPubMedWeb of Science
49. ↵
    1. De Lima L

    (Summer 2001) Advances in palliative care in Latin America and the Caribbean: ongoing projects of the Pan American Health Organization (PAHO). J Palliat Med 4(2):228–231, pmid:11441632.

    OpenUrlPubMed
50. ↵
    1. Joint United Nations Programme on HIV/AIDS (UNAIDS)

    (2013) Global report: UNAIDS report on the global AIDS epidemic (Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Switzerland) http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf. Accessed March 31, 2014.
51. ↵
    1. Clark D,
    2. Wright M,
    3. Hunt J,
    4. Lynch T

    (6, 2007) Hospice and palliative care development in Africa: a multi-method review of services and experiences. J Pain Symptom Manage 33(6):698–710, pmid:17531910.

    OpenUrlCrossRefPubMedWeb of Science
52. ↵
    1. International Narcotics Control Board

    (2011) Global Opioid Consumption (Pain & Policy Studies Group, Madison, WI) http://www.painpolicy.wisc.edu/global. Accessed March 19, 2014.
53. ↵
    1. Cleary J,
    2. Powell RA,
    3. Munene G,
    4. et al.

    Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Africa: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol, 13 Dec; 24 Suppl 11:xi14-xi23.
54. ↵
    1. Joranson DE,
    2. Ryan KM

    (5, 2007) Ensuring opioid availability: methods and resources. J Pain Symptom Manage 33(5):527–532, pmid:17482042.

    OpenUrlCrossRefPubMedWeb of Science
55. ↵
    1. Jagwe JJ,
    2. Merriman AA

    (2007) Uganda: delivering analgesia in rural Africa: opioid availability and nurse prescribing. J Pain Symptom Manage 33:547–551, pmid:17482045.

    OpenUrlCrossRefPubMedWeb of Science
56. ↵
    1. Waldman S

    (2011) Pain Management. 2^nd ed (Elsevier; Philadelphia, PA) ed.
57. ↵
    1. Deshpande CM,
    2. Mohite SN,
    3. Kamdi P

    (8, 2009) Sufentanil vs fentanyl for fast-track cardiac anaesthesia. Indian J Anaesth 53(4):455–462, pmid:20640208.

    OpenUrlPubMed
58. ↵
    1. Macintyre PE,
    2. Jarvis DA

    (1995) A phase 2 multicenter, randomized, placebo-controlled study to evaluate the clinical efficacy, safety, and tolerability of sublingual Sufentanil NanoTab in patients following elective unilateral knee replacement surgery. Pain 64:357–364, pmid:8740614.

    OpenUrlPubMed
59. ↵
    1. Buonsenso D,
    2. Barone G,
    3. Valentini P,
    4. Pierri F,
    5. Riccardi R,
    6. Chiaretti A

    (3 5, 2014) Utility of intranasal ketamine and midazolam to perform gastric aspirates in children: a double-blind, placebo controlled, randomized study. BMC Pediatr 14(1):67, pmid:24598046.

    OpenUrlPubMed